Even small changes in average copayment for long-term controller asthma medications can result in significant reductions in medication use and increases in healthcare services.
Eric M. Maiese, PhD
Advertisement
Articles by Eric M. Maiese, PhD
Advertisement
Latest Updated Articles
- Increasing Pharmaceutical Copayments: Impact on Asthma Medication Utilization and Outcomes
Published: October 11th 2011 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
FDA Approves Cemiplimab as First, Only Adjuvant Immunotherapy for High-Risk CSCC
3
Pulling Back Funding for Research Could Leave HIV Treatment in Worse State: Patrick Sullivan, DVM, PhD
4
Flow Cytometry Tool Could Improve Treatment Monitoring in MS
5
